Process for concentrating blood coagulation Factor XIII derived

Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3548

Patent

active

042859336

ABSTRACT:
The invention relates to a process for concentrating blood coagulation Factor XIII (Fibrin stabilizing factor) which comprises removing a fraction precipitated at a pH of 6 to 9 in a concentration of 4 to 9% (W/V) of an alkylenoxide polymer or copolymer having a molecular weight of 2,000 to 20,000 from a crude globulin fraction obtained from human placentae by separating in albumin fraction therefrom, and then collecting the fraction precipitated in the concentration of 20 to 30% (W/V) of said polymer or copolymer, thereby obtaining easily said blood coagulation Factor XIII free from pyrogen in good yield.

REFERENCES:
patent: 3880989 (1975-04-01), Garcia
Pisano, Ann. N.Y. Acad. Sci., Zoz: 98 (1972).
McDonagh, 16th Int'l Cong. Hematol, Kyoto, (1976).
Mosher, J. Biol. Chem. 250:6614 (1975).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for concentrating blood coagulation Factor XIII derived does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for concentrating blood coagulation Factor XIII derived , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for concentrating blood coagulation Factor XIII derived will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1158336

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.